OrthoPediatrics Corp. Announces First PNP|FEMUR Case Performed in the United Kingdom
OrthoPediatrics Corp. (NASDAQ: KIDS) announced the first surgery in the UK utilizing its new Pediatric Nailing Platform | FEMUR (PNP|FEMUR), aimed at pediatric patients with femoral fractures or deformities. Launched in the US in 2018, the system has now expanded to the UK market. Conducted at Sheffield Children's Hospital, the first case was praised for its advanced and versatile design, aiding complex surgical procedures. OrthoPediatrics continues to innovate in pediatric orthopedics, following extensive feedback from over 6,000 global surgeries.
- Launch of PNP|FEMUR system in the UK expands market reach.
- First surgery in the UK was successful, highlighting system's effectiveness.
- Product based on extensive surgeon feedback from over 6,000 cases.
- Commitment to continuous improvement in pediatric orthopedic technology.
- None.
WARSAW, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced the first surgery in the United Kingdom utilizing the new Pediatric Nailing Platform | FEMUR (“PNP|FEMUR”).
Representing a significant new option for certain anatomies, the PNP|FEMUR system is designed for use in pediatric and small stature adult patients to address femoral fractures or deformity correction procedures. The system launched in the United States in 2018 and is available in the U.K. markets as of this month.
The first case was performed at Sheffield Children’s Hospital by James Fernandes, Consultant Orthopaedic Surgeon. Mr. Fernandes commented, “The new PNP nail is quite advanced and versatile with interesting newer instrumentation elements that will be very handy to the surgeon, especially with difficult and complex cases.”
Joe Hauser, OrthoPediatrics’ Senior Vice President of Trauma & Deformity Correction, stated, “We are extremely pleased to introduce the PNP|FEMUR system to surgeons in the U.K. Our commitment to continuous improvement and innovation in pediatric orthopedics is best represented in the launch of our 3rd generation nailing system, which was built on the shoulders of the original PediNail from over 8 years and 6,000+ cases of global surgeon feedback and experience. This new system has graduated to treat unique pediatric and adolescent anatomies and we are delighted to hear the first case in the U.K. was a great success! We look forward to helping many more children with this technology.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
The Ruth Group
Jan Medina, CFA
(646) 536-7035
jmedina@theruthgroup.com
FAQ
What is the Pediatric Nailing Platform | FEMUR launched by OrthoPediatrics?
Where was the first surgery using the PNP|FEMUR performed?
When did OrthoPediatrics launch the PNP|FEMUR system in the UK?
What feedback influenced the development of the PNP|FEMUR system?
What is the significance of the PNP|FEMUR system for pediatric surgeries?
